Recognizing and Treating Carcinoid Tumors
by Daniel Joo and Nancy LindholmCarcinoid cancer is the term used to refer to tumors that originate in the nerve cells that produce hormones, also known as the neuroendocrine system. About half of these rare tumors begin in the digestive system – the stomach, small intestine, appendix, colon, or rectum. They can also appear in the lungs or, less frequently, in other organs, such as the pancreas or ovaries.
Breakthrough Cancer Pain is Top Challenge for Cancer Patients
Pain is one of the most common, yet misunderstood and feared symptoms of cancer. A survey released in January 2010 by the American Pain Foundation (APF) reveals that breakthrough cancer pain is one of the most challenging aspects of having cancer. The survey also found that breakthrough cancer pain negatively impacts quality of life, contributes to additional financial hardships, and can interfere with one’s ability to cope with other aspects of cancer treatment.
Higher Risk for Heart Disease and Diabetes Associated with Androgen Deprivation Therapy
Men of all ages treated for prostate cancer with androgen deprivation therapy, specifically with gonadotropin-releasing hormone agonists (GnRH), have an increased risk of diabetes and cardiovascular disease, according to a new study published in the Journal of the National Cancer Institute.
Keeping Your Own Medical Records
by Jody Pelusi, PhD, FNP, AOCNP
It’s always a good idea for you to keep your own complete, updated medical records so you can play an active, informed role in your care. This is especially true after a cancer diagnosis. Though this may seem an overwhelming task at first, what you need may be simpler than you think.
Living with Diabetes and Cancer
by Veronica Brady, FNP-BC, BC-ADM, CDE
Glucometer, check. Test strips, check. Lancets, check. Snack, check. Bottled water, check. Diabetes medications, check. Cell phone, check. These items are part of the daily checklist of every person with diabetes leaving home for any length of time. Now imagine this same individual going to a cancer treatment center for a full day of testing, chemotherapy, office visits, etc. Sound familiar?
Maximizing Cancer Pain Management
by Betty Ferrell, RN, PhD, MA, FAAN, FPCN, and Tami Borneman, RN, MSN, CNS, FPCN
Madeline Brown is a 42-year-old woman diagnosed with stage II ovarian cancer. She has responded well to surgery and chemotherapy and in many ways has resumed her life. However, Mrs. Brown has been experiencing pain, pelvic and vaginal discomfort, and moderate to severe peripheral neuropathy. The pain is causing significant disruption in her life. As the months progress and her pain continues, Mrs. Brown becomes anxious and depressed, and her family becomes increasingly concerned.
Drug Treatment for Cutaneous T-cell Lymphoma Approved
The U.S. Food and Drug Administration has approved Gloucester Pharmaceuticals’ Istodax® (romidepsin), an injectable medication, for treatment of people with a rare form of cancer known as cutaneous T-cell lymphoma.
Top Cancer Research Advances of 2009The American Society of Clinical Oncology has released its report Clinical Cancer Advances 2009: Major Research Advances in Cancer Treatment, Prevention and Screening, an independent assessment of the most significant clinical cancer research studies of the past year, including 15 major advances. The report also makes policy recommendations for increasing investment in cancer research funding, accelerating progress in clinical cancer research, and ensuring that Americans with cancer receive high-quality care.